# A Study of Ultra High Dose Diuretics to Treat Heart Failure

> **NCT06036914** · PHASE2 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Heart Failure; With Decompensation

## Interventions

- **DRUG:** Bumetanide
- **DRUG:** Furosemide

## Key facts

- **NCT ID:** NCT06036914
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-11-27
- **Primary completion:** 2024-10-08
- **Final completion:** 2024-10-08
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2026-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06036914

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06036914, "A Study of Ultra High Dose Diuretics to Treat Heart Failure". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT06036914. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*